These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 19997048)
1. 15-deoxy-Delta12,14 prostaglandin GJ2 but not rosiglitazone regulates metalloproteinase 9, NOS-2, and cyclooxygenase 2 expression and functions by peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms in cardiac cells. Hovsepian E; Penas F; Goren NB Shock; 2010 Jul; 34(1):60-7. PubMed ID: 19997048 [TBL] [Abstract][Full Text] [Related]
2. Modulation of inflammatory response and parasitism by 15-Deoxy-Δ(12,14) prostaglandin J(2) in Trypanosoma cruzi-infected cardiomyocytes. Hovsepian E; Mirkin GA; Penas F; Manzano A; Bartrons R; Goren NB Int J Parasitol; 2011 Apr; 41(5):553-62. PubMed ID: 21215746 [TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes. Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742 [TBL] [Abstract][Full Text] [Related]
4. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism. Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073 [TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774 [TBL] [Abstract][Full Text] [Related]
6. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells. Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938 [TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats. Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846 [TBL] [Abstract][Full Text] [Related]
8. HtrA3 is regulated by 15-deoxy-Delta12,14-prostaglandin J2 independently of PPARgamma in clear cell renal cell carcinomas. Théoleyre S; Mottier S; Masson D; Denis MG Biochem Biophys Res Commun; 2010 Apr; 394(3):453-8. PubMed ID: 19951697 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of lipopolysaccharide-induced interleukin-10 by prostaglandin A1 in mouse peritoneal macrophages. Kim HY; Kim JR; Kim HS J Microbiol Biotechnol; 2008 Jun; 18(6):1170-8. PubMed ID: 18600064 [TBL] [Abstract][Full Text] [Related]
10. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells. Chen ZY; Tseng CC Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033 [TBL] [Abstract][Full Text] [Related]
11. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines. Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749 [TBL] [Abstract][Full Text] [Related]
12. The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction. Ponferrada A; Caso JR; Alou L; Colón A; Sevillano D; Moro MA; Lizasoain I; Menchén P; Gómez-Lus ML; Lorenzo P; Cos E; Leza JC; Menchén L Gastroenterology; 2007 May; 132(5):1791-803. PubMed ID: 17484875 [TBL] [Abstract][Full Text] [Related]
13. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells. Chbicheb S; Yao X; Rodeau JL; Salamone S; Boisbrun M; Thiel G; Spohn D; Grillier-Vuissoz I; Chapleur Y; Flament S; Mazerbourg S Biochem Pharmacol; 2011 May; 81(9):1087-97. PubMed ID: 21338579 [TBL] [Abstract][Full Text] [Related]
14. PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes. Mendez M; LaPointe MC Hypertension; 2003 Oct; 42(4):844-50. PubMed ID: 12885795 [TBL] [Abstract][Full Text] [Related]
15. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma). Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2. Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591 [TBL] [Abstract][Full Text] [Related]
17. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1. Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914 [TBL] [Abstract][Full Text] [Related]
18. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B. Berry EB; Keelan JA; Helliwell RJ; Gilmour RS; Mitchell MD Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150 [TBL] [Abstract][Full Text] [Related]
19. Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-kappaB pathways. Chang YC; Li PC; Chen BC; Chang MS; Wang JL; Chiu WT; Lin CH Cell Signal; 2006 Aug; 18(8):1235-43. PubMed ID: 16289764 [TBL] [Abstract][Full Text] [Related]
20. Mechanical loading and delta12prostaglandin J2 induce bone morphogenetic protein-2, peroxisome proliferator-activated receptor gamma-1, and bone nodule formation in an osteoblastic cell line. Siddhivarn C; Banes A; Champagne C; Riché EL; Weerapradist W; Offenbacher S J Periodontal Res; 2007 Oct; 42(5):383-92. PubMed ID: 17760815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]